OR WAIT null SECS
© 2023 MJH Life Sciences™ and Pharmaceutical Commerce. All rights reserved.
Track-and-trace agreement will focus on combating product counterfeiting
In the middle of the ongoing battle against fake goods, two companies that specialize in the fields of pharmaceutical serialization and track and trace have joined together in a strategic partnership: Advanco and Inexto.
Advanco—which last year collaborated with Syntegon for this cause—is a company that focuses on offering highly-regulated, compliance-driven serialization solutions to the pharma sector, while Inexto provides a range of B2B, B2C, and B2G software solutions and services for L1-L5 requirements and regulatory compliance for various industries.
The track-and-trace of serialized goods, in which each product is given a unique identification code (UID), allows for each UID to be tracked along its respective supply chain, from point A to point B.
As a result, track and trace is a process that has been seen as a weapon against illegal trade by illegitimate parties who produce potentially harmful products for unsuspecting consumers of medicines, food and other items. It is also an important deterrent against those who make counterfeit products designed to steal from the legitimate market (e.g., brand owners) and its consumers.
“Advanco and Inexto are delivering proven technologies through this strategic partnership, both in their respective track-and-trace and fully digital authentication solutions,” says Philippe Chatelain, Inexto’s CEO. “Together, this will result in sophisticated solution sets that can be applied across a variety of sectors looking to both effectively and compliantly combat illicit trade.”